Replies to post #123747 on Anavex Life Sciences Corp (AVXL)

[dadofmarcmax]

Do you think the CTAD presentation PR would be coupled with "the PR of PRs" or do you think that whatever is discussed at CTAD is the "PR of PRs?"

I think the CTAD presentation will introduce the design protocol and explain why the trial will be conducted as it will be conducted. While (hopefully) huge news in and of itself, I fear that if this is the only news (trial design and start date) without other news of partnership coupled together, AVXL will once again be at the whims of the market makers.

I do believe that with the extended quiet period and the other trials starting close together, there has to be prodigious amounts of information to divulge that will overwhelm any short activity especially if the expected surge in buying volume comes with great news.

It seems, to me, that the setup (and our patient long wait as longs) is complete. Things seems to be just about ready.

Expect me to chime in more from the clinical perspective once there is more science to chew on.

[nidan7500]

treden...GREAT POST. Thanks

I believe once Dr. Missling finally starts to garner attention around the trial starts he isnt going to play the same tune as before letting the "circus" control the narrative. He is bringing the big guns with him this time and when he speaks people in high places will start to finally listen and crowd around. The days of cheap conferences are going to be over. Soon it will be standing room only when Missling is in attendance

IMO, AVXL and A2-73 and Gottlieb/Missling etal are all about CHANGE...which some do not do well at.